StonvexLoading…
StonvexStonvexStonvexCore line items from ORLY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $17.78B | $16.71B | $15.81B | $4.20B |
Operating Income | $3.46B | $3.25B | $3.19B | $897.22M |
Net Income | $2.54B | $2.39B | $2.35B | $649.83M |
EPS (Diluted) | $2.97 | $2.71 | $2.56 | $10.72 |
Total Assets | $16.54B | $14.89B | $13.87B | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $193.79M | $130.25M | $279.13M | Not available |
Free Cash Flow OCF − CapEx | $1.59B | $2.03B | $2.03B | Not available |
Shares Outstanding | 841.91M | 862.23M | 59.07M | Not available |